R W Burlingame

806 total citations
11 papers, 640 citations indexed

About

R W Burlingame is a scholar working on Molecular Biology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R W Burlingame has authored 11 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Rheumatology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R W Burlingame's work include Systemic Lupus Erythematosus Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (3 papers). R W Burlingame is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and T-cell and B-cell Immunology (3 papers). R W Burlingame collaborates with scholars based in United States, Australia and Singapore. R W Burlingame's co-authors include Robert L. Rubin, M L Boey, Gordon Starkebaum, Terry W. Du Clos, Lorraine L. Marnell, Carolyn Mold, Michelle Petri, LS Magder, Ehtisham Akhter and James Harris and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

R W Burlingame

11 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R W Burlingame United States	9	407	295	181	136	96	11	640
Z Awdeh United States	8	448 1.1×	157 0.5×	108 0.6×	110 0.8×	46 0.5×	14	726
M F Gourley United States	7	477 1.2×	566 1.9×	280 1.5×	123 0.9×	44 0.5×	10	887
Mieke C.J. van Bruggen Netherlands	15	475 1.2×	478 1.6×	274 1.5×	120 0.9×	27 0.3×	21	769
C T Ravirajan United Kingdom	18	624 1.5×	621 2.1×	416 2.3×	137 1.0×	31 0.3×	34	946
Noam Jacob United States	13	562 1.4×	406 1.4×	202 1.1×	143 1.1×	53 0.6×	24	824
Bernie Scallon Sweden	5	234 0.6×	200 0.7×	103 0.6×	125 0.9×	115 1.2×	6	639
Rebecca Subang Canada	15	252 0.6×	350 1.2×	68 0.4×	98 0.7×	30 0.3×	27	568
Wasilis Kolowos Germany	12	696 1.7×	239 0.8×	47 0.3×	235 1.7×	43 0.4×	13	863
Devesh Mewar United Kingdom	11	198 0.5×	330 1.1×	94 0.5×	93 0.7×	30 0.3×	18	571
H. Alrayes Saudi Arabia	8	338 0.8×	313 1.1×	76 0.4×	135 1.0×	42 0.4×	13	560

Countries citing papers authored by R W Burlingame

Since Specialization

Citations

This map shows the geographic impact of R W Burlingame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R W Burlingame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R W Burlingame more than expected).

Fields of papers citing papers by R W Burlingame

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R W Burlingame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R W Burlingame. The network helps show where R W Burlingame may publish in the future.

Co-authorship network of co-authors of R W Burlingame

This figure shows the co-authorship network connecting the top 25 collaborators of R W Burlingame. A scholar is included among the top collaborators of R W Burlingame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R W Burlingame. R W Burlingame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Akhter, Ehtisham, et al.. (2011). Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus. 20(12). 1267–1274. 84 indexed citations

Gómez‐Puerta, José A., R W Burlingame, & Ricard Cervera. (2006). Anti-Chromatin (Anti-Nucleosome) Antibodies. Lupus. 15(7). 408–411. 19 indexed citations

Burlingame, R W, et al.. (1996). The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice. The Journal of Immunology. 156(12). 4783–4788. 55 indexed citations

Marnell, Lorraine L., et al.. (1995). C-reactive protein binds to Fc γ RI in transfected COS cells. The Journal of Immunology. 155(4). 2185–2193. 136 indexed citations

Rubin, Robert L., et al.. (1995). IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus.. The Journal of Immunology. 154(5). 2483–2493. 33 indexed citations

Suzuki, Takahiro, et al.. (1994). Antihistone antibodies in systemic lupus erythematosus: assay dependency and effects of ubiquitination and serum DNA.. PubMed. 21(6). 1081–91. 16 indexed citations

Burlingame, R W, M L Boey, Gordon Starkebaum, & Robert L. Rubin. (1994). The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.. Journal of Clinical Investigation. 94(1). 184–192. 252 indexed citations

Clos, Terry W. Du, et al.. (1991). Analysis of the binding of C-reactive protein to chromatin subunits. The Journal of Immunology. 146(4). 1220–1225. 26 indexed citations

Moudrianakis, Evangelos N., Warner E. Love, & R W Burlingame. (1985). Crystallographic Structure of the Octamer Histone Core of the Nucleosome. Science. 229(4718). 1113–1113. 2 indexed citations

10.

Moudrianakis, Evangelos N., et al.. (1985). Response : Crystallographic Structure of the Octamer Histone Core of the Nucleosome. Science. 229(4718). 1110–1112. 6 indexed citations

11.

Burlingame, R W, Gilles Thomas, Richard L Stevens, Karl Schmid, & H. W. Moser. (1981). Direct quantitation of glycosaminoglycans in 2 mL of urine from patients with mucopolysaccharidoses.. Clinical Chemistry. 27(1). 124–128. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact